Please login to the form below

Not currently logged in

New dosing option for AZ’s Imfinzi approved in the EU and UK

AZ NEWAdditional option extends dosing from two weeks to four weeks

Bayer’s finerenone scores FDA priority review for chronic kidney disease

Bayer symbolFDA priority review is based on data from the phase 3 FIDELIO-DKD trial

J&J could launch its single-dose COVID-19 vaccine in March

J&J cottonwood driveChief scientific officer Paul Stoffels said J&J is aiming for one billion doses in 2021

Merck wins speedy FDA review for 15-valent pneumococcal vaccine

Merck & Co HQPfizer's rival 20-valent candidate was granted priority review in December 2020

AZ seeks EU approval for its Oxford University-partnered COVID-19 vaccine

AZ NEWCHMP could reach a decision on opinion by 29 January

Roche’s flu pill Xofluza gains EU approval

Roche Basel SwitzerlandEU approval is based on results from three phase 3 studies

UK approves Moderna’s COVID-19 vaccine, secures another 10 million doses

LondonTotal number of doses secured by UK now totals 17 million

EMA recommends authorisation of Moderna’s COVID-19 vaccine

Eu flag 2020 newEuropean Commission likely to formally approve the vaccine soon

Brexit‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’

Brexit means pharma must review its intellectual property rights across Europe

Latest regulatory appointments

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...